Emerrx BioPharma: A Faster Way to Reverse Overdose
On this episode of Invst Guru, host Jeff “Fuzzy” Wenzel interviews Mitch Raponi, the CEO and Co-Founder of Emerrx BioPharma, a startup developing next-generation drug delivery solutions for emergency medicine.
Mitch explains how their flagship product, MRX-101, uses a novel dual-chamber intranasal device that delivers naloxone with near-IV speed — a critical advancement in overdose reversal technology. He also shares insights into Emerrx’s fundraising journey, capital-efficient model, and the potential expansion of their platform into other lifesaving drugs.
If you’re interested in biotech innovation, impact investing, or startup strategy, this episode offers a rare look inside a company working to make a real difference.
Highlights include:
- The science and urgency behind faster naloxone delivery
- Emerrx’s roadmap to FDA engagement and commercialization
- Building an ethical, efficient startup team
- Leveraging crowdfunding for biotech growth
🎧 Listen now and discover how science, innovation, and compassion are coming together to fight the opioid epidemic.
Hosted on Acast. See acast.com/privacy for more information.
